Literature DB >> 24712334

Granulocyte-reactive antibodies are associated with red blood cell alloimmunization.

M Schönbacher1, M W Heinzl, E-M Dauber, W R Mayr, S Panzer, G F Körmöczi.   

Abstract

Granulocyte-reactive antibodies may cause transfusion-related acute lung injury (TRALI) and immune neutropenias. Risk factors for their acquisition other than previous alloexposition are largely unknown. In addition to the known association between human leucocyte antigen alloantibodies and red blood cell alloimmunization in selected cohorts of transfused patients, this study investigated a possible extension of this association to granulocyte-reactive antibodies in women with a history of pregnancy. The overall prevalence of granulocyte-reactive antibodies in 333 samples from women with a history of pregnancy (143 samples containing red cell alloantibodies) was 23·1%. The prevalence in the red cell-alloimmunized group (32·9%) was significantly higher than in controls (15·8%, P < 0·001). This could suggest that some individuals may be strong immunological responders, forming alloantibodies more readily than others.
© 2014 International Society of Blood Transfusion.

Entities:  

Keywords:  RBC antigens and antibodies; human neutrophil antigens; immunohaematology; trali

Mesh:

Substances:

Year:  2014        PMID: 24712334     DOI: 10.1111/vox.12152

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  2 in total

1.  Antibodies against human neutrophil antigens in non-transfused women with red blood cell alloimmunisation induced by pregnancy.

Authors:  Juliana Oliveira Martins; Elyse Moritz; Samira A Abbas; Larissa B Lopes; Melca M O Barros; Akemi K Chiba; Dante M Langhi; José O Bordin
Journal:  Blood Transfus       Date:  2020-10-14       Impact factor: 3.443

2.  Leukocyte-Reactive Antibodies in Female Blood Donors: The Austrian Experience.

Authors:  Marlies Schönbacher; Nicole Aichinger; Lisa Weidner; Christof Jungbauer; Christoph Grabmer; Beate Schuha; Eva Rohde; Wolfgang Mayr; Günther Körmöczi
Journal:  Transfus Med Hemother       Date:  2020-09-23       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.